TrialCardiovascular diabetology2025

Effect of Empagliflozin on the plasma lipidome in patients with type 2 diabetes mellitus: results from the EmDia clinical trial.

Katrin I Bauer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.